Chimeric murine/human IgG(2) anti-tenascin 81C6 monoclonal antibody: phase I trial in patients with malignant glioma of a construct with improved stability

Journal Article

Full Text

Duke Authors

Cited Authors

  • Zalutsky, MR; Reardon, DA; Quinn, JA; Coleman, RE; Akabani, G; Friedman, AH; Friedman, HS; II, HJE; McLendon, RE; Wong, TZ; Bigner, DD

Published Date

  • September 2006

Published In

Volume / Issue

  • 33 /

Start / End Page

  • S194 - S194

International Standard Serial Number (ISSN)

  • 1619-7070